SCYNEXIS Stock

SCYNEXIS Earnings Yield

The Earnings Yield of SCYNEXIS (SCYX) as of Aug 5, 2026 is -67.64 %. In the previous year, Earnings Yield was 213.01 % — a change of -131.75% (lower).

Earnings Yield

-67.64 %

YoY

-131.75%

Last updated:

Earnings Yield of SCYNEXIS is 2026 -67.64 % . Earnings Yield of SCYNEXIS was 2025 213.01 % . It decreases by -131.75% lower compared to the previous year.
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

Earnings Yield of SCYNEXIS is -67.64 % in 2026.

Earnings Yield of SCYNEXIS changed from 213.01 % to -67.64 %, representing a -131.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's SCYNEXIS with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — SCYNEXIS

All Key Metrics — SCYNEXIS